Associazione Nazionale Medici Cardiologi Ospedalieri

CONGRESS ABSTRACT

CONGRESS ABSTRACT

VITAMIN D AND CARDIOVASCULAR DISEASE: 3 THE “GOOD”, THE “BAD” AND THE “UNKNOWN”

Giamundo Domenico Mario Roma (Rm) – Policlinico Casilino | Spadafora Luigi Latina (Lt) – Ospedale Santa Maria Goretti | Bernardini Marco Roma (Rm) – Università Di Roma La Sapienza | Sabouret Pierre Parigi (Pg) – Università Sorbona Parigi | Golino Michele New York (Ny) – Università Virginia Ny

Vitamin D is a key regulator of calcium and phosphorus homeostasis and the most common nutritional deficiency worldwide. Over the past decades, the discovery of vitamin D receptors and conversion enzymes within the cardiovascular system has fueled growing interest in its potential roles beyond bone health. Preclinical studies have suggested that vitamin D might regulate vascular tone and exert antifibrotic and anti-remodeling effects on the myocardium. Furthermore, a deficit of vitamin D has been associated with an increased risk of hypertension, atherosclerosis, and heart failure. These findings have spurred several interventional studies investigating whether vitamin D supplementation could mitigate cardiovascular risk. However, current evidence regarding its cardiovascular benefits remains inconsistent and inconclusive. In this review, we provided a comprehensive overview of the “good,” the “bad,” and the “unknown” aspects of the relationship between vitamin D and cardiovascular disease.